期刊文献+

VEGF、ER、PR及AR在颈鼓室副神经节瘤的表达

The Expressions of VEGF,ER, PR or AR in Jugulotympanic Paraganglioma
下载PDF
导出
摘要 目的观察血管内皮生长因子(vascular endothelial growth factor,VEGF)及雌激素受体(estrogen receptor,ER)、孕激受体(progestogen receptor,PR)、雄激素受体(androgen receptor,AR)在颈鼓室副神经节瘤的表达,分析其与肿瘤生物学行为的关系。方法回顾性分析17例颈鼓室副神经节瘤的临床资料,对其存档的手术标本行Envision法免疫组织化学检查,并运用SPSS 10.0 for Windows对资料进行Spearman等级相关分析。结果在17例标本中,11例表达VEGF,且表达强度与Fisch分级相关,r=0.529,P<0.05;无1例表达ER、PR及AR。结论 VEGF可能对颈鼓室副神经节瘤的生长有促进作用;颈鼓室副神经节瘤的性别偏向似乎与性激素异常无关。 Purpose To observe the expressions of vascular endothelial growth factor (VEGF) , estrogen receptor (ER) ,progestogen receptor (PR) or androgen receptor (AR) in jugulotympanic paraganglioma. Methods Clinical materials from 17 cases of jugulotympanic paraganglioma were analyzed retrospectively. The archival specimens were examined immunohistochemically. Spearman rank correlation was executed using SPSS 10.0 for Windows. Results 11 archival specimens (11/17)expressed VEGF. None of them expressed ER, PR or AR. VEGF expression levels were correlated with Fisch classifications (r = 0.529, P < 0.05). Conclusion VEGF may accelerate the growth of jugulotympanic paraganglioma. It seems that sex predilection of jugulotympanic paraganglioma has nothing to do with sex hormones.
出处 《中国眼耳鼻喉科杂志》 2003年第6期359-360,共2页 Chinese Journal of Ophthalmology and Otorhinolaryngology
关键词 VEGF ER PR AR 颈鼓室副神经节瘤 血管内皮生长因子 雌激素受体 孕激受体 雄激素受体 jugulotympanic paraganglioma vascular endothelial growth factor (VEGF) estrogen receptor (ER) progestogen receptor (PR) androgen receptor (AR)
  • 相关文献

参考文献7

  • 1Jyung RW, Leclair EE, Bemat R A, et al. Expression of angiogenic growth factors in paragliomas. Laryngoscope,2000,110(1) : 161-167.
  • 2Balli R, Dallari S, Bergamini G, et al. A vascular tympanojugular jparaganglioma.Laryngoscope, 1996,106(6) :721-723.
  • 3Hyder SM, Stancel GM. Inhibition of progesterone-induced VEGF production in human breast cancer cells by the pure antiestrogen ICI 182,780. Cancer Lett ,2002,181 ( 1 ) :47-53.
  • 4Jenkins HA, Fisch U. Glomus tumors of the temporal region.Technique of surgical resection.Arch Otolaryngol, 1981,107(4) :209-214.
  • 5Rolt T, Velkavrh D. Our experience with the enhanced polymer one step staining in frozen sectiion. Acta Otolaryngol, 1997,527(Suppl) : 114-115.
  • 6Battifora H. Assessment of antigen damage in immunohistochemistry. The vimentin internal eontrtd. Am J Clin Pathol, 1991,96(5) :669-671.
  • 7Dvorak HF, Vascular permeability factor/vascular endothdial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. Clinic Oncol,2002,20(21 ) :43458-4380.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部